BLOG

Safety and Side Effects of Adipose Stem Cell Therapy in Osaka

Published 2026.10.10 8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When people research regenerative medicine, the first question is often what the treatment might do. A more useful question for a careful patient is what could go wrong, and how a clinic manages that possibility. This article explains how to think about risks and side effects of adipose-derived stem cell therapy, so that you arrive at a consultation with Grand Green Osaka Umekita Clinic, or any clinic, with informed questions.

Short answer: every medical treatment has risks, and they should be discussed in person

No medical treatment is free of risk, and stem cell therapy is no exception. Adipose-derived stem cell therapy is a self-pay (non-insured) treatment in Japan, and outcomes vary between individuals. Whether it is suitable for you, what risks apply to your situation, and what side effects may occur can only be judged by a physician after reviewing your medical history and current health. Be cautious of any source that describes a regenerative treatment as risk-free or promises a particular result.

Where risks can arise in the treatment process

Adipose-derived stem cell therapy involves several steps, and each step carries its own considerations. Understanding the flow helps you ask specific questions rather than general ones.

Fat collection: a small amount of fat tissue is taken under local anesthesia. As with other minor procedures, bruising, swelling, discomfort, bleeding, or infection at the collection site can occur, and reactions to the anesthetic are possible.
Cell culture: the cells are cultured and expanded at a specialized facility. The main concerns here are contamination and quality control, which is why the handling standards of the facility matter.
Intravenous infusion: the cultured cells are given by IV drip. Reported reactions to infusions in general include temporary fever, chills, or a feeling of being unwell, and any infusion carries a small risk of infection or irritation at the needle site.

Because the cells come from your own body, the risk of rejection or allergic reaction is generally considered lower than with donor cells. Lower does not mean absent, and other components used in culture or infusion can still matter. Ask the physician which materials are used and whether you have any allergies that are relevant.

What the research says, and what it does not say

Studies of mesenchymal stem cells, including those from adipose tissue, have been published in many countries, and reviews of early-phase trials have generally described acceptable short-term tolerability in the populations studied. However, these studies differ in cell dose, route of administration, patient group, and follow-up length. Findings from one study cannot simply be applied to another condition or another clinic.

Long-term safety data are still more limited than for established standard treatments. It is therefore reasonable to ask a physician how the available evidence relates to your own situation, how certain the evidence is, and what is still unknown. A good consultation should make room for uncertainty rather than hide it. Stem cell therapy should also not be understood as a replacement for standard medical care that your doctor has recommended.

How Japan’s regulatory framework relates to safety

In Japan, regenerative medicine provided by clinics falls under the Act on the Safety of Regenerative Medicine. Providers must have their treatment plan reviewed by a certified committee and then submit it to the authorities, and cell culture is expected to take place at facilities that meet specified standards. This framework is intended to support safety management, but it is not a guarantee of results or of freedom from adverse events.

As a patient, you can ask the clinic to explain which plan covers the treatment, how adverse events are recorded and handled, and what the arrangements are if you feel unwell after returning home. Clear answers to these practical questions are a sign that a clinic takes safety management seriously.

Questions worth bringing to your consultation

Writing your questions down beforehand makes a consultation more productive, especially if you are communicating in a second language. The following list may help you get started.

Which risks and side effects are most relevant to my age, health conditions, and medications?
Are there conditions or circumstances in which this treatment is not suitable for me?
What are the total costs, the number of visits, and the expected timeline, and what is not included?
What happens if I develop a fever or other symptoms after treatment, and who should I contact?
How is follow-up arranged if I live outside Osaka or outside Japan?
What are the alternatives, including standard treatment, and what would happen if I chose not to proceed?

Bring a list of your current medications, past surgeries, allergies, and any medical records from your home country. Sharing this information openly helps the physician assess risks accurately. If you have a serious condition such as cancer, an autoimmune disease, or a clotting disorder, tell the physician at the start, because it may affect whether this treatment is appropriate.

Considering treatment in Osaka as an international patient

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka and offers information pages for international patients, including in English. If you are planning to travel, it is wise to think about practical safety as well: how long you can stay in Japan after treatment, how you would reach a medical facility if a problem arose, and how your own doctor at home can be kept informed. These points are best discussed before you decide, not after.

Adipose-derived stem cell therapy is a self-pay treatment, and fees, risks, side effects, and suitability are confirmed during a consultation with a physician. The decision is yours to make calmly, with accurate information, and without pressure. If a clinic cannot or will not discuss risks openly, that in itself is useful information.

Summary

Risks can arise at the fat collection, culture, and infusion stages, and published evidence is encouraging in some respects but still limited, particularly over the long term. Japan’s regulatory framework supports safety management without guaranteeing outcomes. Prepare specific questions, share your full medical history, and confirm costs, risks, and alternatives with a physician before making any decision.

Where to Ask About Risks

1Fat collectionLocal anesthesia
2Cell cultureQuality control
3IV infusionPossible reactions
4Follow-upWho to contact

This figure is a conceptual diagram that organizes the content of the article

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›